Transcat, Inc. (TRNS) Stake Lifted by Vanguard Group Inc
Vanguard Group Inc lifted its holdings in Transcat, Inc. (NASDAQ:TRNS) by 1.6% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 253,133 shares of the scientific and technical instruments company’s stock after purchasing an additional 3,945 shares during the quarter. Vanguard Group Inc’s holdings in Transcat were worth $5,785,000 as of its most recent filing with the SEC.
Several other large investors have also added to or reduced their stakes in the company. First Trust Advisors LP acquired a new stake in shares of Transcat in the third quarter valued at $235,000. O Shaughnessy Asset Management LLC lifted its holdings in shares of Transcat by 11,400.8% in the third quarter. O Shaughnessy Asset Management LLC now owns 14,031 shares of the scientific and technical instruments company’s stock valued at $321,000 after buying an additional 13,909 shares during the period. Bailard Inc. lifted its holdings in shares of Transcat by 39.6% in the third quarter. Bailard Inc. now owns 14,456 shares of the scientific and technical instruments company’s stock valued at $330,000 after buying an additional 4,100 shares during the period. Wagner Bowman Management Corp acquired a new stake in shares of Transcat in the third quarter valued at $372,000. Finally, BlackRock Inc. lifted its holdings in shares of Transcat by 20.5% in the second quarter. BlackRock Inc. now owns 23,596 shares of the scientific and technical instruments company’s stock valued at $446,000 after buying an additional 4,014 shares during the period. 58.01% of the stock is owned by institutional investors.
NASDAQ:TRNS traded down $0.36 during mid-day trading on Monday, hitting $23.51. 5,143 shares of the company’s stock traded hands, compared to its average volume of 26,063. Transcat, Inc. has a 12 month low of $13.90 and a 12 month high of $25.35. The company has a market cap of $172.08 million, a price-to-earnings ratio of 33.11, a PEG ratio of 3.47 and a beta of 0.94. The company has a quick ratio of 1.45, a current ratio of 2.16 and a debt-to-equity ratio of 0.40.
In other Transcat news, Director Gary J. Haseley bought 3,500 shares of the firm’s stock in a transaction that occurred on Tuesday, November 20th. The stock was purchased at an average price of $20.43 per share, for a total transaction of $71,505.00. Following the purchase, the director now directly owns 20,150 shares in the company, valued at $411,664.50. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 8.80% of the stock is owned by corporate insiders.
Several equities research analysts recently issued reports on the company. Zacks Investment Research raised Transcat from a “hold” rating to a “buy” rating and set a $24.00 price objective for the company in a research note on Thursday, January 17th. ValuEngine raised Transcat from a “hold” rating to a “buy” rating in a research report on Monday, February 4th.
Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Featured Article: What Are Treasury Bonds?
Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS).
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.